Conflict of interest: The authors declare no potential conflict of interest.
Version of Record online: 31 DEC 2012
Copyright © 2012 Wiley Periodicals, Inc.
Pediatric Blood & Cancer
Volume 60, Issue 7, pages 1135–1140, July 2013
How to Cite
Moreno, L., Vaidya, S. J., Pinkerton, C. R., Lewis, I. J., Imeson, J., Machin, D., Pearson, A. D. J. and on behalf of the European Neuroblastoma Study Group and the Children's Cancer and Leukaemia Group (CCLG) (formerly UKCCSG) (2013), Long-term follow-up of children with high-risk neuroblastoma: The ENSG5 trial experience. Pediatr. Blood Cancer, 60: 1135–1140. doi: 10.1002/pbc.24452
Presented in part at the Advances in Neuroblastoma Research 14th Conference, June 21–24, 2010, Stockholm, Sweden.
- Issue online: 22 MAY 2013
- Version of Record online: 31 DEC 2012
- Manuscript Accepted: 27 NOV 2012
- Manuscript Received: 10 AUG 2012
- Oak Foundation
Additional Supporting Information may be found in the online version of this article.
|pbc_24452_sm_SuppTabI.docx||14K||Supplementary Table I. Assessments and investigations on ENSG5|
|pbc_24452_sm_SuppTabII.docx||14K||Supplementary Table II. Description of neuroblastoma survivors that received other therapies after ENSG5 trial|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.